Comparison of conventional and high-sensitivity troponin in patients with chest pain: a collaborative meta-analysis

Michael J Lipinski1, Nevin C Baker1, Ricardo O Escárcega1

  • 1MedStar Cardiovascular Research Network, MedStar Heart Institute, Medstar Washington Hospital Center, Washington, DC.

American Heart Journal
|December 16, 2014
PubMed

Insights

High-sensitivity troponin (hs-cTn) offers greater early sensitivity and negative predictive value for diagnosing acute myocardial infarction (AMI) compared to conventional troponin (cTn). However, hs-cTn shows reduced specificity and positive predictive value, impacting early AMI rule-out.

Area of Science:

  • Cardiology
  • Biomarkers
  • Diagnostic Testing

Background:

  • Conventional troponin (cTn) and high-sensitivity troponin (hs-cTn) have been evaluated for acute myocardial infarction (AMI) diagnosis and prognosis.
  • Studies comparing cTn and hs-cTn performance in patients with chest pain are numerous.

Purpose of the Study:

  • To conduct a collaborative meta-analysis comparing cTn and hs-cTn for AMI diagnosis and prognosis.
  • To assess the diagnostic and prognostic performance of both troponin assays.

Main Methods:

  • A systematic literature search of MEDLINE/PubMed, Cochrane CENTRAL, and EMBASE was performed.
  • Included studies assessed both cTn and hs-cTn in patients presenting with chest pain.
  • Previously unpublished data were obtained from study authors.

Main Results:

  • In 8,644 patients from 17 studies, hs-cTn demonstrated significantly higher sensitivity (0.884 vs 0.749) and NPV (0.964 vs 0.935) than cTn.
  • Specificity (0.816 vs 0.938) and PPV (0.558 vs 0.759) were significantly reduced with hs-cTn.
  • hs-cTn elevation with negative cTn predicted increased risk of death or nonfatal myocardial infarction during follow-up.

Conclusions:

  • High-sensitivity troponin offers improved early sensitivity and NPV for AMI diagnosis, aiding in early rule-in/rule-out decisions.
  • The trade-off for improved sensitivity with hs-cTn includes reduced specificity and PPV.
  • Elevated hs-cTn with a negative cTn result is a significant predictor of adverse cardiovascular events post-discharge.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
484
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.9K
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
446
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
631
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
813